[1] Yang L, Ling Y, Guo L, et al. Detection of ALK translocation in non-small cell lung carcinoma (NSCLC) and its clinicopathological significance using the Ventana immunohistochemical staining method:a single-center large-scale investigation of 1, 504 Chinese Han patients[J]. Chin J Cancer Res, 2016, 28(5):495-502. [2] Cheng Y, Leng W, Zhang J. Protective Effect of Puerarin Against Oxidative Stress Injury of Neural Cells and Related Mechanisms[J]. Med Sci Monit, 2016, 22:1244-1249. [3] Ai F, Chen M, Yu B, et al. Puerarin accelerate scardiac angiogenesis and improves cardiac function of myocardial infarction by upregulating VEGFA, Ang-1 and Ang-2 in rats[J]. Int J Clin Exp Med, 2015, 8(11):20821-20828. [4] 魏述永. 葛根素心血管保护作用及其机制研究进展[J]. 中国中药杂志, 2015, 40(12):2278-2284. [5] Wang Y, Ma Y, Zheng Y, et al. In vitro and in vivo anticancer activity of a novel puerarin nanosuspension against colon cancer, with high efficacy and low toxicity[J]. Int J Pharm, 2013, 441(1-2):728-735. [6] Guo XF, Yang ZR, Wang J, et al. Synergistic antitumor effect of puerarin combined with 5-fluorouracil on gastric carcinoma[J]. Mol Med Rep, 2015, 11(4):2562-2568. [7] Chen YY, Chen J, Zhou XM, et al. Puerarin protects human umbilical vein endothelial cells against high glucose-induced apoptosis by upregulating heme oxygenase-1 and inhibiting calpain activation[J]. Fundam Clin Pharmacol, 2012, 26(3):322-331. [8] Xu X, Wang J, Zhang H, et al. Puerarin reduces apoptosis in rat hippocampal neurons culturea in high glucose medium by modulating the p38 mitogen activated protein kinase and c-Jun N-terminal kinase signaling pathways[J]. J Tradit Chin Med, 2016, 36(1):78-84. [9] Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor[J]. Biochem Biophys Res Commun, 1998, 251(2):471-476. [10] McLean DL, Kim J, Kang Y, et al. Apelin/APJ signaling is a critical regulator of statin effects in vascular endothelial cells——brief report[J]. Arterioscler Thromb Vasc Biol, 2012, 32(11):2640-2643. [11] Zeng XX, Wilm TP, Sepich DS, et al. Apelin and its receptor control heart field formation during zebrafish gastrulation[J]. Dev Cell, 2007, 12(3):391-402. [12] Hamada J, Baasanjav A, Ono N, et al. Possible involvement of downregulation of the apelin-APJ system in doxorubicin-induced cardiotoxicity[J]. Am J Physiol Heart Circ Physiol, 2015, 308(8):H931-941. [13] Sorli S C, Le Gonidec S, Knibiehler B, et al. Apelin is a potent activator of tumour neoangiogenesis[J]. Oncogene, 2007, 26(55):7692-7699. [14] Berta J, Kenessey I, Dobos J, et al. Apelin Expression in Human Non-small Cell Lung Cancer:Role in Angiogenesis and Prognosis[J]. J Thorac Oncol, 2010, 5(8):1120-1129. [15] Wang Z, Greeley GH, Jr Qiu S. Immunohistochemical localization of apelin in human normal breast and breast carcinoma[J]. J Mol Histol, 2008, 39(1):121-124. |